Features of hepatocellular carcinoma in Hispanics differ from African Americans and non-Hispanic Whites

Neeta K Venepalli1, Mary V Modayil1, Stephanie A Berg1

  • 1Neeta K Venepalli, Tad D Nair, Mayur Parepally, Priyanka Rajaram, Yue Huang, Department of Medicine, Section of Hematology/Oncology, University of Illinois at Chicago, Chicago, IL 60612, United States.

Insights

Hispanic patients with hepatocellular carcinoma (HCC) face higher risks of metabolic conditions like nonalcoholic steatohepatitis (NASH) and experience shorter overall survival (OS). This highlights disparities in HCC outcomes among racial groups.

Area of Science:

  • Hepatology
  • Oncology
  • Epidemiology

Background:

  • Hepatocellular carcinoma (HCC) is a significant global health concern.
  • Understanding racial and ethnic disparities in HCC is crucial for targeted interventions.
  • Previous research indicates variations in HCC characteristics across different populations.

Purpose of the Study:

  • To compare the clinical and demographic features of hepatocellular carcinoma (HCC) in Hispanic patients against those in African American and White patients.
  • To identify specific risk factors and comorbidities associated with HCC in the Hispanic population.

Main Methods:

  • Retrospective analysis of 195 patients diagnosed with HCC between 2005 and 2011 at an urban tertiary medical center.
  • Data collection included demographics, comorbidities, liver disease characteristics, tumor parameters, treatment, and overall survival (OS).
  • Kaplan-Meier method was used for overall survival analyses.

Main Results:

  • Hispanic patients (22.6%) were more likely to have diabetes, hyperlipidemia, nonalcoholic steatohepatitis (NASH), and end-stage renal disease compared to African American (31.2%) and White (46.2%) patients.
  • Hispanic patients had a lower incidence of hepatitis C virus (HCV) and smoking history.
  • Hispanic patients exhibited higher MELD scores, ascites, and encephalopathy, and experienced shorter overall survival (OS) than other racial groups.

Conclusions:

  • Hispanic patients with HCC demonstrate a higher prevalence of modifiable metabolic risk factors, including NASH.
  • These patients experience significantly shorter overall survival (OS) compared to African American and White patients.
  • Findings underscore the need for focused strategies to address metabolic health and improve HCC outcomes in Hispanic populations.
Abstract

Related Concept Videos

Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
64
Stereotypes, Prejudice, and Discrimination02:55

Stereotypes, Prejudice, and Discrimination

Humans are very diverse and although we share many similarities, we also have many differences. The social groups we belong to help form our identities (Tajfel, 1974). These differences may be difficult for some people to reconcile, which may lead to prejudice toward people who are different. Prejudice is a negative attitude and feeling toward an individual based solely on one’s membership in a particular social group (Allport, 1954; Brown, 2010). Prejudice is common against people who...
95.9K
Surveys02:16

Surveys

Often, psychologists develop surveys as a means of gathering data. Surveys are lists of questions to be answered by research participants, and can be delivered as paper-and-pencil questionnaires, administered electronically, or conducted verbally. Generally, the survey itself can be completed in a short time, and the ease of administering a survey makes it easy to collect data from a large number of people.
17.1K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
244
Test for Homogeneity01:23

Test for Homogeneity

The goodness–of–fit test can be used to decide whether a population fits a given distribution, but it will not suffice to decide whether two populations follow the same unknown distribution. A different test, called the test for homogeneity, can be used to conclude whether two populations have the same distribution. To calculate the test statistic for a test for homogeneity, follow the same procedure as with the test of independence. The hypotheses for the test for homogeneity can...
2.5K